Interaction of insulin and Burkholderia cepacia

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Outbreak of campylobacter food-poisoning in Northern Ireland
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.
Outbreak of campylobacter food-poisoning in Northern Ireland
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Interaction of insulin and Burkholderia cepacia
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
P.M. Keig, E. Ingham, P.A.R. Vandamme, K.G. Kerr 
Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium  M. Denton, M.J. Hall, N.J.
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin  Ornella Soro, Adelaide.
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Enterobacterial intergenic consensus sequence polymerase chain reaction as a typing method for Burkholderia (Pseudomonas) cepacia  Nevio Cimolai, Colleen.
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Andrew M. Middleton, Maureen V. Chadwick, Harold Gaya 
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
Joanne L. Tipper, Eileen Ingham, Jonathan H. Cove, Neil J
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity  R.J.L.F. Loffeld, C.A.P.M.J.
Carratalà J.   Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip  M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Interaction of insulin and Burkholderia cepacia Sarah Jeromson, Paula Keig, Kevin Kerr  Clinical Microbiology and Infection  Volume 5, Issue 7, Pages 439-442 (July 1999) DOI: 10.1111/j.1469-0691.1999.tb00169.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Growth of Burkholderia cepacia strain 10661 at 37°C in nutrient broth in the presence (▪) and absence (⋄) of 10 IU/mL of pharmaceutical-grade recombinant human insulin containing 0.3% (w/v) m-cresol. Clinical Microbiology and Infection 1999 5, 439-442DOI: (10.1111/j.1469-0691.1999.tb00169.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Growth of Burkholderia cepacia strain 10661 at 37°C in nutrient broth in the presence (▪) and absence (⋄) of 10 IU/mL recombinant human insulin without preservative. Clinical Microbiology and Infection 1999 5, 439-442DOI: (10.1111/j.1469-0691.1999.tb00169.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.